Biosimilars Forum Sees Lessons Being Learned From US Humira Experience
Executive Director Julie Reed Says Low Uptake For Adalimumab Has Gained Attention
In an interview with Generics Bulletin, Julie Reed, executive director of the US Biosimilars Forum, says that the low uptake for Humira rivals in the US has “raised everyone’s attention to what is going on and what is wrong with the system.”
